Opioid Use Disorder Treatment Medications
Earlier this week AHCCCS announced that they’ve accepted the recommendations of their Pharmacy and Therapeutics Committee and will be adding an additional buprenorphine medication (sublingual) to their preferred formulary list and a streamlined prior authorization process for a long acting injectable medication (effective 10/1). Here’s the story from the Republic and the Cap Times.
Hacienda Healthcare Enforcement Action
The ADHS issued a Notice of Intent to Revoke the license of a Hacienda Healthcare on Friday (here’s the story from the Republic). Apparently, a patient at the facility had larvae on a stoma, prompting the investigation. As you’ll recall, the facility previously had not been required to have a license – until SB1211 was passed and signed. The Governor signed the law with an emergency implementation clause (making it immediately effective) on 4/24/19.
A survey was conducted on 4/23 & 4/24 (that found no deficiencies) and the facility was apparently issued a license on 4/26. According to the news report staff from 3 state agencies (ADHS, AHCCCS, and ADES) are monitoring the facility and working on an investigation.
